Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes
Background and aim: Fuzheng Huayu Recipe (FZHY) is a Chinese patent medicine (approval No. Z20020074) included in the national medical insurance catalogue, which is mainly used for anti-hepatic fibrosis treatment of hepatitis B virus (HBV) induced liver fibrosis and liver cirrhosis. In clinical prac...
Saved in:
Main Authors: | Lu Xing (Author), Rui Zeng (Author), Kai Huang (Author), Jingbo Xue (Author), Hongliang Liu (Author), Zhimin Zhao (Author), Yuan Peng (Author), Xudong Hu (Author), Chenghai Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of <it>Fuzheng Huayu </it>formula and its actions against liver fibrosis
by: Xu Lieming, et al.
Published: (2009) -
Is the function of the HBeAg really unknown?
by: David R. Milich
Published: (2019) -
Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I-induced kidney fibrosis through network pharmacology
by: Fan Wang, et al.
Published: (2022) -
Relation of hepatitis B core antigen expression with histological activity, serum HBeAg, and HBV DNA levels
by: Aysegul Sari, et al.
Published: (2011) -
Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
by: Gao F, et al.
Published: (2021)